Concord Drugs Limited (CONCORD) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE858L01010
₹75.00+3.99 (+5.62%)
Key metrics
- Market Cap
- ₹99 Cr
- P/E Ratio
- 44.64
- EPS
- 1.68
- Book Value
- 36.82
- P/B Ratio
- 2.04
- ROE
- 2.17%
- ROCE
- 5.13%
- Debt / Equity
- 0.28
- Net Margin
- 1.34%
- Revenue Growth
- 74.02%
- Profit Growth
- 213.8%
- Dividend Yield
- —
- 52W High
- ₹92.52
- 52W Low
- ₹51.08
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Concord Drugs Limited
Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products; ready-to-fill pellets and multiple unit pellets system; other drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. The company was incorporated in 1995 and is based in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Promoter Holding
- 71.93%
The full Concord Drugs Limited analysis
Create a free account to open the complete CONCORD deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.